Market closed

Prestige Consumer Healthcare/$PBH

14:30

16:10

17:45

19:25

21:00

1D1W1MYTD1Y5YMAX

About Prestige Consumer Healthcare

Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.

Ticker

$PBH

Sector

Health Care

Trading on

NYSE

Industry

Pharmaceuticals

Headquarters

Tarrytown, United States

Employees

570

Website

www.prestigebrands.com

PBH Metrics

BasicAdvanced

$3.7B

18.20 $4.10

0.47 -

Price and volume

Market cap

$3.7B

Beta

0.47

52-week high

$84.65

52-week low

$58.22

Average daily volume

263K

Financial strength

Current ratio

3.561

Quick ratio

2.012

Long term debt to equity

61.107

Total debt to equity

61.26

Interest coverage (TTM)

5.68%

Management effectiveness

Return on assets (TTM)

6.12%

Return on equity (TTM)

12.61%

Valuation

Price to earnings (TTM)

18.202

Price to revenue (TTM)

3.345

Price to book

2.13

Price to tangible book (TTM)

-3.31

Price to free cash flow (TTM)

14.589

Growth

Revenue change (TTM)

-1.45%

Earnings per share change (TTM)

-348.47%

3-year revenue growth (CAGR)

2.81%

3-year earnings per share growth (CAGR)

5.01%

What the Analysts think about PBH

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Prestige Consumer Healthcare stock.

PBH Financial Performance

Income Statement

Revenues and expenses

QuarterlyAnnual

Q3 24

QoQ growth

Revenue

$37B

-39.75%

Net income

$45B

107.52%

Profit margin

37.65%

6.78%

PBH Earnings Performance

Earnings per share (EPS)

Company profitability

QuarterlyAnnual

Q4 23

Q1 24

Q2 24

Q3 24

Q4 24

Actual

$3.69

$2.85

$2.45

$2.42

-

Expected

$3.55

$2.61

$2.05

$2.31

$3.94

Surprise

3.94%

9.20%

19.51%

4.63%

-

PBH News

AllArticlesVideos

Prestige Consumer Healthcare Inc (PBH) Q2 2025 Earnings Call Transcript

Seeking Alpha·2 months ago

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.

Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $PBH

$

Capital at risk

Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Prestige Consumer Healthcare stock?

Prestige Consumer Healthcare (PBH) has a market cap of $3.7B as of January 15, 2025.

What is the P/E ratio for Prestige Consumer Healthcare stock?

The price to earnings (P/E) ratio for Prestige Consumer Healthcare (PBH) stock is 18.2 as of January 15, 2025.

Does Prestige Consumer Healthcare stock pay dividends?

No, Prestige Consumer Healthcare (PBH) stock does not pay dividends to its shareholders as of January 15, 2025.

When is the next Prestige Consumer Healthcare dividend payment date?

Prestige Consumer Healthcare (PBH) stock does not pay dividends to its shareholders.

What is the beta indicator for Prestige Consumer Healthcare?

Prestige Consumer Healthcare (PBH) has a beta rating of 0.47. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.